We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.3B
AUM Growth
+$344M
Cap. Flow
-$120M
Cap. Flow %
-1.64%
Top 10 Hldgs %
25.93%
Holding
453
New
22
Increased
155
Reduced
213
Closed
25

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$71.7M
2
TFC icon
Truist Financial
TFC
+$56.3M
3
OXY icon
Occidental Petroleum
OXY
+$45.9M
4
VTR icon
Ventas
VTR
+$23.4M
5
SE
Spectra Energy Corp Wi
SE
+$23.1M

Top Sells

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$80.4M
2
KMI icon
Kinder Morgan
KMI
+$55.8M
3
MRSH
Marsh
MRSH
+$55.4M
4
USB icon
US Bancorp
USB
+$47.7M
5
TWX
Time Warner Inc
TWX
+$35.9M

Sector Composition

Rank Sector Weight
1 Technology 15.34%
2 Consumer Staples 15.34%
3 Financials 15.05%
4 Healthcare 14.65%
5 Industrials 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CM icon
376
Canadian Imperial Bank of Commerce
CM
$108B
$252K ﹤0.01%
7,660
IEFA icon
377
iShares Core MSCI EAFE ETF
IEFA
$194B
$252K ﹤0.01%
4,630
-10,160
-69% -$564K
TRIB
378
Trinity Biotech
TRIB
$7.86M
$251K ﹤0.01%
142
-105
-43% -$186K
ELV icon
379
Elevance Health
ELV
$84.9B
$248K ﹤0.01%
1,778
-28
-2% -$3.86K
AET
380
DELISTED
Aetna Inc
AET
$248K ﹤0.01%
2,294
CSX icon
381
CSX Corp
CSX
$93.9B
$242K ﹤0.01%
27,930
DGS icon
382
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.76B
$239K ﹤0.01%
+6,823
New +$251K
PID icon
383
Invesco International Dividend Achievers ETF
PID
$917M
$235K ﹤0.01%
17,270
ABB
384
DELISTED
ABB Ltd
ABB
$234K ﹤0.01%
13,200
-100
-0.8% -$1.84K
VIVO
385
DELISTED
Meridian Bioscience Inc
VIVO
$234K ﹤0.01%
11,400
RAI
386
DELISTED
Reynolds American Inc
RAI
$234K ﹤0.01%
5,074
-270
-5% -$12.5K
SI
387
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$234K ﹤0.01%
2,435
+38
+2% +$3.65K
BBWI icon
388
Bath & Body Works
BBWI
$4.06B
$229K ﹤0.01%
2,959
-33
-1% -$2.56K
HUM icon
389
Humana
HUM
$44.1B
$229K ﹤0.01%
+1,283
New +$225K
RAVN
390
DELISTED
Raven Industries Inc
RAVN
$229K ﹤0.01%
14,641
-2,370
-14% -$41.2K
ADM icon
391
Archer Daniels Midland
ADM
$37.4B
$222K ﹤0.01%
6,062
+200
+3% +$8.01K
BEN icon
392
Franklin Resources
BEN
$17.3B
$221K ﹤0.01%
6,000
EWS icon
393
iShares MSCI Singapore ETF
EWS
$1.06B
$221K ﹤0.01%
10,733
-2,100
-16% -$45.3K
STT icon
394
State Street
STT
$50.8B
$221K ﹤0.01%
3,331
+181
+6% +$12.6K
NNN icon
395
NNN REIT
NNN
$8.94B
$220K ﹤0.01%
5,500
-1,000
-15% -$38.1K
HY icon
396
Hyster-Yale Materials Handling
HY
$662M
$216K ﹤0.01%
4,119
-2,950
-42% -$169K
VIG icon
397
Vanguard Dividend Appreciation ETF
VIG
$114B
$216K ﹤0.01%
2,782
-595
-18% -$46.4K
FBIN icon
398
Fortune Brands Innovations
FBIN
$6.01B
$214K ﹤0.01%
+4,512
New +$204K
UNFI icon
399
United Natural Foods
UNFI
$2.9B
$214K ﹤0.01%
5,440
-7,355
-57% -$344K
BIIB icon
400
Biogen
BIIB
$30.5B
$212K ﹤0.01%
+692
New +$199K

Similar funds

Bahl & Gaynor's Q4 2015 Portfolio in Review

As of Q4 2015, Bahl & Gaynor held 453 positions worth $7.3B, up 4.9% from $6.96B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Bahl & Gaynor's Q4 2015 filing shows 22 new, 155 increased, 213 reduced and 25 closed positions. Its largest new stake was Equifax: 109,123 shares worth $12.2M. The largest sale was Williams Companies, an estimated $80.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Staples and Financials.

  • Bahl & Gaynor's largest Q4 2015 buy was Equifax: 109,123 shares worth $12.2M.
  • Bahl & Gaynor added most to Crown Castle in Q4 2015, an estimated $71.7M increase.
  • Bahl & Gaynor's biggest Q4 2015 reduction was Williams Companies, cutting an estimated $80.4M.
  • Bahl & Gaynor fully exited Kinder Morgan in Q4 2015, selling an estimated $55.8M.
  • Bahl & Gaynor's ten largest holdings make up 26% of its $7.3B portfolio in Q4 2015.
  • Bahl & Gaynor opened 22 new positions and closed 25 in Q4 2015.
  • Bahl & Gaynor's portfolio value rose 4.9% quarter-over-quarter to $7.3B.

Based on Bahl & Gaynor's 13F filing for Q4 2015, filed 12 Feb 2016.